With eyes on tokenized gold, the companies plan to merge and launch a gold-backed treasury business.
BioSig and Streamex have secured $1.1 billion in growth financing to support their pivot into onchain commodities, starting with gold.
The companies, which signed a letter of intent to merge on May 5, say the funding will help establish a gold-backed treasury business focused on tokenized financial instruments. Of the total funding, $100 million comes in the form of convertible debentures, while the remaining $1 billion is an equity line of credit.
BioSig’s share price has fallen 27.4% on the news on Tuesday, though it is still up 541% in the past six months.
Read more
If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.
If you want to read more News articles, you can visit our General category.
